We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
LeMaitre Vascular
LMAT
$2.26B
| $2.98M | ﹤0.01% |
44,940
-38,432
| -46% | -$2.37M |
|
1177
Lam Research
LRCX
$365B
| $2.97M | ﹤0.01% |
+30,570
| New | +$2.69M |
|
1178
Federal Signal
FSS
$7.22B
| $2.96M | ﹤0.01% |
+34,899
| New | +$2.73M |
|
1179
Taysha Gene Therapies
TSHA
$1.59B
| $2.96M | ﹤0.01% |
+1,030,657
| New | +$2.15M |
|
1180
Rekor Systems
REKR
$86M
| $2.94M | ﹤0.01% |
+1,285,727
| New | +$3.54M |
|
1181
IQVIA
IQV
$35.6B
| $2.94M | ﹤0.01% |
+11,636
| New | +$2.72M |
|
|
INST
1182
DELISTED
Instructure Holdings, Inc.
INST
| $2.94M | ﹤0.01% |
+137,436
| New | +$3.24M |
|
1183
LifeMD
LFMD
$187M
| $2.93M | ﹤0.01% |
285,118
-36,773
| -11% | -$272K |
|
1184
Victory Capital Holdings
VCTR
$6.23B
| $2.93M | ﹤0.01% |
69,014
-57,871
| -46% | -$2.13M |
|
1185
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
| $2.93M | ﹤0.01% |
23,400
-134,200
| -85% | -$15.8M |
|
1186
Advantage Solutions
ADV
$504M
| $2.92M | ﹤0.01% |
27,007
+5,257
| +24% | +$517K |
|
1187
Cabaletta Bio
CABA
$444M
| $2.92M | ﹤0.01% |
+171,187
| New | +$3.67M |
|
1188
OneSpan
OSPN
$562M
| $2.92M | ﹤0.01% |
250,827
+159,614
| +175% | +$1.64M |
|
1189
Matador Resources
MTDR
$5.86B
| $2.91M | ﹤0.01% |
43,510
-46,200
| -51% | -$2.75M |
|
1190
Mesa Laboratories
MLAB
$540M
| $2.9M | ﹤0.01% |
26,413
+10,566
| +67% | +$1.06M |
|
1191
Restaurant Brands International
QSR
$25.8B
| $2.89M | ﹤0.01% |
36,385
+31,585
| +658% | +$2.46M |
|
1192
Boyd Gaming
BYD
$6.64B
| $2.88M | ﹤0.01% |
+42,774
| New | +$2.73M |
|
1193
Gran Tierra Energy
GTE
$238M
| $2.88M | ﹤0.01% |
402,954
+122,172
| +44% | +$680K |
|
1194
CALL
Starbucks
SBUX
$118B
| $2.86M | ﹤0.01% |
37,800
-145,400
| -79% | -$13.5M |
|
1195
Wheels Up
UP
$219M
| $2.86M | ﹤0.01% |
+49,772
| New | +$3.28M |
|
1196
Fidelity Blue Chip Growth ETF
FBCG
$6.75B
| $2.85M | ﹤0.01% |
74,060
+22,836
| +45% | +$824K |
|
1197
Arcturus Therapeutics
ARCT
$164M
| $2.85M | ﹤0.01% |
+84,267
| New | +$2.99M |
|
1198
Acadia Healthcare
ACHC
$2.99B
| $2.84M | ﹤0.01% |
+35,883
| New | +$2.93M |
|
1199
Grindr
GRND
$2.75B
| $2.84M | ﹤0.01% |
+280,253
| New | +$2.49M |
|
1200
Capital Group Global Growth Equity ETF
CGGO
$11.3B
| $2.83M | ﹤0.01% |
+98,151
| New | +$2.67M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.